Typewriter Therapeutics Raises $56 Million Series A for In Vivo CAR T Platform

Typewriter Therapeutics has emerged from stealth with $56 million in Series A financing to advance an RNA-based gene insertion platform... Read More

The post Typewriter Therapeutics Raises $56 Million Series A for In Vivo CAR T Platform appeared first on citybiz.